Delivery Order SPE2DB22D2214-SPE2DB24FS3UB
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,594,660 BOTOX 200 unit vials. The delivery order, valued at $11,642.60, has a completion date of February 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA...
- This is a $10,336.32 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,568,568,836 units of BOTOX 100 UNIT VIALS. The contract has an ultimate completion date of July 8, 2025 and was awarded on June 13, 2025. The contract is not set-aside and allows for the delivery of both brand-name and generic medications. Amerisourcebergen Drug Corp holds a significant...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The order is for 200 unit vials of BOTOX medication, with a potential value of $5,821.30 and a completion date of March 25, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing pharmaceuticals and medical supplies to U.S. government agencies, including the...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,578,733 units of BOTOX 200 unit vials. The contract has a completion date of February 28, 2024 and a potential value of $6,985.56. This delivery order is part of a larger Indefinite Delivery Contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which serves as the primary contract...
- This is a firm-fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $85,479.00, is for the delivery of 4,568,523,812 BOTOX 200 UNIT VIALS. The contract has an ultimate completion date of July 3, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,767.00 firm fixed-price contract is for the delivery of 4,568,530,658 units of BOTOX 100 unit vials, with a completion date of July 3, 2025. The contract is not set aside for any specific socioeconomic category. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- The U.S. Defense Logistics Agency (DLA) awarded a $61,123.65 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4,564,667,812 units of BOTOX 200 unit vials. This order is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
- This is a $13,971.12 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 200-unit vials of Botox. The contract has an ultimate completion date of September 11, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of its broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract, valued at $6,985.56, is for the delivery of 200-unit vials of the pharmaceutical product BOTOX. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corporation by DLA, with a potential value of...
- This is a $6,029.52 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 unit vials of BOTOX. The contract has an ultimate completion date of July 15, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB24FS3UBDelivery Order
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The order is for the supply of 4,563,856,622 units of BOTOX 200 UNIT VIALS with a potential value of $6,985.56 and a completion date of March 22, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used for this award. This order is issued under a larger indefinite delivery contract (IDC) between Amerisourcebergen Drug Corp and DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 3/1/24 |